HDST-M Stock Overview
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
HBL - Hadasit Bio-Holdings Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪0.53 |
52 Week High | ₪1.59 |
52 Week Low | ₪0.40 |
Beta | 0.83 |
1 Month Change | 0.19% |
3 Month Change | -11.50% |
1 Year Change | -64.55% |
3 Year Change | -91.84% |
5 Year Change | -88.91% |
Change since IPO | -99.82% |
Recent News & Updates
Shareholder Returns
HDST-M | IL Biotechs | IL Market | |
---|---|---|---|
7D | 0.2% | 3.2% | 2.9% |
1Y | -64.6% | 4.6% | 10.8% |
Return vs Industry: HDST-M underperformed the IL Biotechs industry which returned 4.6% over the past year.
Return vs Market: HDST-M underperformed the IL Market which returned 10.8% over the past year.
Price Volatility
HDST-M volatility | |
---|---|
HDST-M Average Weekly Movement | 17.5% |
Biotechs Industry Average Movement | 8.2% |
Market Average Movement | 4.4% |
10% most volatile stocks in IL Market | 8.3% |
10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: HDST-M's share price has been volatile over the past 3 months.
Volatility Over Time: HDST-M's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 2 | Yoram Azulai | www.hbl.co.il |
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer.
HBL - Hadasit Bio-Holdings Ltd Fundamentals Summary
HDST-M fundamental statistics | |
---|---|
Market cap | ₪5.89m |
Earnings (TTM) | -₪29.19m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.2x
P/E RatioIs HDST-M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HDST-M income statement (TTM) | |
---|---|
Revenue | ₪0 |
Cost of Revenue | ₪0 |
Gross Profit | ₪0 |
Other Expenses | ₪29.19m |
Earnings | -₪29.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.63 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 26.5% |
How did HDST-M perform over the long term?
See historical performance and comparison